Skip to main content

Electrophoretic Deposition of α-Fe2O3/Chitosan Nanocomposite Coatings for Functional and Biomedical Applications

Buy Article:

$107.14 + tax (Refund Policy)

Promising composite coatings based on hematite (α-Fe2O3) mesocrystals of size 110 nm and chitosan (CHT) molecules for different biotechnological applications have been successfully obtained by electrophoretic deposition (EPD). Homogeneous and reproducible coatings have been obtained by studying and controlling the chemical interactions between both phases (α-Fe2O3) and CHT). A voltage of 25 V and a deposition time of 5 min were chosen as best deposition conditions, which resulted in highly homogeneous coatings with well-distributed α-Fe2O3 particles. According to TGA measurements, the content of α-Fe2O3 and chitosan in the final composite coating were found to be 74 and 26 wt%, respectively. The presence of both phases in the composite coating was determined by XRD analysis and the coatings microstructure was observed by SEM.

Document Type: Research Article

Publication date: 01 December 2015

More about this publication?
  • Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content